Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Current Assets (2020 - 2025)

GeneDx Holdings has reported Current Assets over the past 6 years, most recently at $268.3 million for Q4 2025.

  • Quarterly results put Current Assets at $268.3 million for Q4 2025, up 35.52% from a year ago — trailing twelve months through Dec 2025 was $268.3 million (up 35.52% YoY), and the annual figure for FY2025 was $268.3 million, up 35.52%.
  • Current Assets for Q4 2025 was $268.3 million at GeneDx Holdings, up from $237.6 million in the prior quarter.
  • Over the last five years, Current Assets for WGSWW hit a ceiling of $538.5 million in Q3 2021 and a floor of $99.0 million in Q2 2021.
  • Median Current Assets over the past 5 years was $212.9 million (2022), compared with a mean of $254.0 million.
  • Biggest five-year swings in Current Assets: soared 36647.87% in 2021 and later tumbled 56.03% in 2022.
  • GeneDx Holdings' Current Assets stood at $483.5 million in 2021, then plummeted by 56.03% to $212.6 million in 2022, then decreased by 14.24% to $182.3 million in 2023, then increased by 8.57% to $198.0 million in 2024, then soared by 35.52% to $268.3 million in 2025.
  • The last three reported values for Current Assets were $268.3 million (Q4 2025), $237.6 million (Q3 2025), and $204.8 million (Q2 2025) per Business Quant data.